VACANCY: TRIAL COORDINATOR

The Helse Nord Tuberculosis Initiative (HNTI) under the Same Day ART initiation among Presumptive TB Patients (SADAPT) study aims to compare two guideline-approved approaches for the timing of ART initiation among HIV positive individuals with presumptive TB but no signs of Central Nervous System disease (“ART first” versus “TB results first”) regarding HIV viral suppression, engagement in care, and adverse events in a pragmatic randomised trial reflecting routine primary and secondary care settings in Southern Africa.

The Helse Nord Tuberculosis Initiative (HNTI) is a collaborative programme between the Kamuzu University of Health Sciences (KUHES), Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW), and Helse Nord RHF of the University of Tromsø in Norway. HNTI supports collaborative and multidisciplinary tuberculosis (TB) research within the KUHeS with the long-term goal of building local scientific research capacity that is sustainable, internationally excellent and that makes a direct contribution to local and international TB diagnostic capacity control policy and practice.

The study is therefore inviting applications for the position of Trial Coordinator under the following conditions: 

Reporting to:             Research Study Principal Investigator

Location:                    Kamuzu University of Health Sciences, Blantyre Campus

Duration:                   1-year contract

DUTIES AND RESPONSIBILITIES

  • Prepare and track submissions to the relevant Research Ethics Committees and Regulatory Authority and ensure appropriate approval has been obtained for all trial related activities.
  • Assist the Principal Investigators (PIs) in the description, definition and preparation of source documents.
  • Ensure document control protocol is in place.
  • Ensure all study Standard Operating Procedures (SOPs) are in place and written.
  • Assist the Co-Principal Investigators (CIs), and Principal Investigators in reviewing the protocol for completeness, accuracy, and improvement opportunities.
  • Assists PIs to assure that all key personnel or persons ‘engaged’ in the research project have met training requirements in accordance with regulations and sponsoring agency policies and procedures
  • Monitoring study accounts and the study budget with the Principal Investigator and study finance manager
  • Assist the CI, Principal Investigators and project manager to oversee the conduct of clinical research in accordance with Good Clinical Practices, Regulatory Authority, and sponsoring agency policies and procedures.
  • Organise, attend and document meetings or events relevant to the trial’s start-up, conduct and closure.
  • Prepare for Study Site Initiation.
  • Assist with Community Awareness Initiatives.
  • Organise, participate and document staff training
  • Oversee the day-to-day coordination of the trial.
  • Assist the Scientific Administrator to oversee operational, administrative and Human Resource matters.
  • Assist in the maintenance and development of a trial database to track trial participant’s progress, and monitor, follow-up and participant adherence
  • Ensure trial statistics are maintained to monitor trial recruitment targets, and subject retention figures.
  • Assist the CI and PIs in checking data for errors and attending to and
    documentation of any queries raised.
  • Ensure adequate quality control and quality assurance systems are in place.
  • Preparation for, and facilitation of, monitoring visits, audits and/or inspections.
  • Facilitate communication between study sites, and HNTI, ensure that all clinical trial data is collected, recorded, and processed to agreed timelines, in accordance with International Conference on Harmonization Good Clinical Practice (ICH GCP) and as specified in the study protocol.
  • Assist with the notification and reporting of Serious Adverse Events to Sponsor, or relevant Research Ethics Committees and Regulatory Authority, as appropriate.
  • Keep appraised of current legislation/guidelines and best practice and disseminate as appropriate.
  • Participate in weekend and out of hours working/stand by cover as part of the senior management rota.
  • Prepare for Study closure and archiving of essential documents in accordance with local policy.

QUALIFICATIONS

  • Minimum of a Bachelor’s Degree in Nursing or Diploma in Clinical Medicine
  • At least 2 years’ experience in the management and conduct of clinical trials
  • Experience in HIV/AIDS and TB research and/or ART provision will be an added advantage

GENERAL ATTRIBUTES

The ideal candidate should have the following attributes:

  • Excellent oral and written skills in English.
  • Good computer skills including internet, email, and MS Office proficiency.
  • Good interpersonal skills and the ability to work in a team.
  • Able to consistently follow procedures and systems put in place.
  • Good problem identification and solving skills.
  • Excellent records management and document control experience
  • Knowledge of and compliance with national standards of clinical governance and audit
  • Excellent organizational and coordination skills

APPLICATION PROCEDURE

Suitably qualified candidates should forward their applications in pdf format in one file together with copies of certificates and detailed Curriculum Vitae with names contact numbers and emails of three traceable referees. Applications should be submitted via email to:

The Registrar

Kamuzu University of Health Sciences

P/Bag 360

Chichiri

Blantyre 3

hr@medcol.mw and HNTI@medcol.mw

Applications should be received no later than 15th April 2022. Only short-listed candidates will be acknowledged.

VACANCY: RESEARCH NURSE (3)

The Helse Nord Tuberculosis Initiative (HNTI) under the Same Day ART initiation among Presumptive TB Patients (SADAPT) study aims to compare two guideline-approved approaches for the timing of ART initiation among HIV positive individuals with presumptive TB but no signs of Central Nervous System disease (“ART first” versus “TB results first”) regarding HIV viral suppression, engagement in care, and adverse events in a pragmatic randomised trial reflecting routine primary and secondary care settings in Southern Africa.

The Helse Nord Tuberculosis Initiative (HNTI) is a collaborative programme between the Kamuzu University of Health Sciences (KUHES), Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW), and Helse Nord RHF of the University of Tromsø in Norway. HNTI supports collaborative and multidisciplinary tuberculosis (TB) research within the KUHeS with the long-term goal of building local scientific research capacity that is sustainable, internationally excellent and that makes a direct contribution to local and international TB diagnostic capacity control policy and practice.

The study wishes to engage three (3) research nurses who would be required to work full-timeunder the SADAPT study in Ndirande, Bangwe, and Limbe Health Centers under the following conditions: 

Reporting to:              Trial Coordinator

Location:                    Kamuzu University of Health Sciences, Blantyre Campus

Duration:                   1-year contract

DUTIES AND RESPONSIBILITIES

  • Assessing participant enrollment criteria and conducting informed consent
  • Collecting biological samples from participants
  • Documenting and maintaining accurate records of study participant visits and procedures
  • Ensuring that study procedures and protocols are followed
  • Coordinating and working closely with hospital staff and community leaders on study project activities
  • Assisting with sample organization, storage, and transport
  • Compile clinical data and enter it into a database
  • Collaborate with investigators and statistical consultants

QUALIFICATIONS

  • Diploma or Bachelor of Science in Nursing or Nursing and Midwifery
  • Experience in HIV/AIDS and TB research and/or ART provision will be an added advantage.

GENERAL ATTRIBUTES

The ideal candidate should have the following attributes:

  • Excellent oral and written skills in English.
  • Proficiency in using computers, particularly working with ls including internet, email, and MS Office proficiency.
  • Interested in clinical or public health research
  • Good interpersonal skills and the ability to work in a team.
  • Able to consistently follow procedures and systems put in place.
  • Good problem identification and solving skills.

APPLICATION PROCEDURE

Suitably qualified candidates should forward their applications in pdf format in one file together with copies of certificates and detailed Curriculum Vitae, names and contact numbers and emails of three traceable referees. Applications should be submitted via email to:

The Registrar

Kamuzu University of Health Sciences

P/Bag 360

Chichiri

Blantyre 3

hr@medcol.mw and HNTI@medcol.mw

Applications should be received no later than 15th April 2022. Only short-listed candidates will be acknowledged.

Course Announcement: Concise Good Clinical Practices

COURSE ANNOUNCEMENT

CONCISE GOOD CLINICAL PRACTICE

Facilitation: Research Support Centre

Dates:  11th April, 2022

Venue: Kamuzu University of Health Sciences, Blantyre Campus Research Support Centre Conference Room

Course Fee $100

The course is offered by Research Support Centre (RSC), a centre with renowned history

of delivering high quality training courses and services in clinical trial monitoring, data

Management and communication. RSC’s courses are delivered by highly qualified

Facilitators, guaranteeing the trainees of invaluable training standards.

Target Audience: Investigators, Clinical Trial Managers & Coordinators, Study Clinicians,

Medical Doctors, Clinical Officers, Medical Assistants, Research Nurses, Laboratory

Technicians, Laboratory Assistants, Data Managers, Data Officers, Trial Coordinators,

Field Officers and all interested Health Professionals.

Pre-requisite: clinical research experience

About the course: This course will cover the following 12 modules and an assessment:

  • Phases of Clinical Research
  • Key Players in Clinical Trials,
  • Principles of Good Clinical Practice (GCP,
  • Clinical Research  Protocol,
  • Informed Consent Process,
  • Ethics Committees and Regulatory Authorities,
  • Managing Investigational Product
  • Adverse Events  – Safety Reporting,
  • Principles of Documentation,
  • Monitoring, Audits and Inspections,
  • Quality control and Quality Assurance
  • Site preparation and Management

Course fee: $100 per participant. Course fees cover course material, lunch and refreshments.

Target Audience:  Principal Investigators, study coordinators, project managers, quality control officers, research managers, and all interested research staff.

Application deadline: Follow this link to apply for this course: https://forms.gle/RCfA2pvimjDFhLMa6

FUNDING OPPORTUNITIES

FEBRUARY 2022 FUNDING OPPORTUNITY

  1. Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages exploratory/developmental research grant applications, piloting innovative, collaborative research projects with low- and middle-income country (LMIC) institutions/ scientists on brain and other nervous system-related function and disorders throughout life, relevant to LMICs. Research on the full spectrum of neuro-health, neurological, neuromuscular, sensory, neuropsychiatric, cognitive, behavioral and neurodevelopmental function and disorders may span the full range of science from basic to clinical to translation and implementation research. Scientists in LMIC institutions may partner with scientists in other LMIC institutions and/or U.S. institutions . Income categories are defined by the World Bank at http://data.worldbank.org/about/country-classifications/country-and-lending-groups).

Link: https://grants.nih.gov/grants/guide/pa-files/PAR-22-098.html

Application deadline:

November 15, 2022,

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

2. Biomarker Signatures of TB Infection in Young Children With and Without HIV (R01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to advance research to discover and validate novel biomarkers of Tuberculosis (TB) infection and subsequent risk of progression to TB disease in young children with and without HIV.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-015.html

Application deadline: June 08, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

3. Investigating Transposable Elements and Mobile DNA as Targets of Integration for Establishing HIV Reservoirs in the Brain (R61/R33 – Clinical Trial Optional)

The purpose of this funding opportunity announcement (FOA) is to support research examining the potential contributions of mobile DNA elements and addictive substances in HIV integration, reservoir formation, and maintenance in the brain. NIDA is specifically interested in studies exploring the contributions of molecular, genetic, and epigenetic factors in HIV integration, reservoir formation, and maintenance in microglia and/or the brain in the context of addiction.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-003.html

Application deadline: August 03, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

4. Integrating Mental Health Care into Health Care Systems in Low- and Middle-Income Countries (R01 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites implementation research applications to develop, optimize, and test innovative theory-based strategies to integrate mental and physical health care within health care systems in low-and middle-income countries (LMICs). This FOA aims to support innovative research for implementing, scaling up, and financially sustaining integrated mental health care models to ultimately increase demand and utilization, quality, access, and availability of mental health care. This FOA is also expected to contribute to the long-term goals of strengthening the sustainable research capacity in LMICs and enhancing the potential for multidirectional knowledge and the exchange of research advancements. NIMH encourages partnerships between institutions in LMICs and high-income-countries (HICs).

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-003.html

Application deadline: June 22, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

5. BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed)

This FOA solicits applications for research projects that seek to understand how circuit activity gives rise to mental experience and behavior using innovative, methodologically-integrated approaches. The goal is to support adventurous projects that can realize a potentially transformative outcome within 5 years. Applications are expected to address circuit function in the context of specific behaviors or neural systems, such as sensation, perception, attention, reasoning, intention, decision-making, emotion, navigation, communication, or homeostasis. Projects should link theory, data analysis, and/or computational approaches to experimental design and should produce predictive models (conceptual or quantitative). Projects should aim to improve the understanding of circuits of the central nervous system by systematically controlling stimuli and/or behavior while actively recording and/or manipulating dynamic patterns of neural activity. Diverse species or experimental systems and a cross-species/comparative approach are welcome and should be chosen based on their power to address the specific question at hand and to reveal generalizable and fundamental neuroscience principles.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-026.html

Application deadline: July 01, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

6. Limited Competition: NIH Neuroscience Doctoral Readiness Program (DR. Program) (R25 Clinical Trial Not Allowed)

This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective approaches to biomedical research education and mentoring that will keep pace with the rapid evolution of the research enterprise. This Neuroscience Doctoral Readiness Program (DR Program) expects that the proposed research education programs will incorporate extensive research experiences within the participating NIH Institutes missions and well-designed courses for skills development and education to prepare recent baccalaureates from diverse backgrounds to transition into and complete rigorous, research-focused doctoral degree programs (e.g., Ph.D., M.D./Ph.D., or D.D.S./Ph.D.) in biomedical fields.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-035.html

Application deadline: April 19, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

8. Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage innovative pilot research that will inform and support the delivery of high-quality, continuously improving mental health services to benefit the greatest number of individuals with, or at risk for developing, a mental illness. This announcement invites applications for non-clinical trial pilot projects that address NIMH strategic priorities to strengthen the public health impact of NIMH-supported research as described in Goal 4 of the NIMH Strategic Plan.

Link: https://grants.nih.gov/grants/guide/pa-files/PAR-22-082.html

Application date line:

June 16, 2022,

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

9. Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required)

NIMH is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). See “Determination that a Public Health Emergency Exists Nationwide as the Result of the 2019 Novel Coronavirus” as renewed in “Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of Coronavirus Disease 2019 (COVID-19) Pandemic“. This Funding Opportunity Announcement (FOA) aims to address urgent, time-sensitive mental health research questions related to COVID-19, including broader secondary impacts of the pandemic as well as research on the intersection of mental health, COVID-19, and HIV. Research supported will improve public health in the near term by informing responses to the current pandemic through rapid acceleration of research to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions to respond to new and worsening mental illness and HIV-related outcomes among those who experience COVID-19 as well as the broader population impacted by the pandemic. All research is anticipated to focus on particularly vulnerable populations based on existing evidence of increased mental health symptoms and illness and preexisting health disparities.

Link: https://grants.nih.gov/grants/guide/pa-files/PAR-22-112.html

Application Date Line: April 25, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

10. BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) solicits applications to develop informatics tools for analyzing, visualizing, and integrating data related to the BRAIN Initiative or to enhance our understanding of the brain. As part of programs of building the informatics infrastructure for the BRAIN Initiative, the FOA supports several different, but related activities. These include modifying existing analysis and visualization tools to deal with BRAIN Initiative data and integrating different types of BRAIN Initiative datasets. Proposing the development of new tools to deal with BRAIN Initiative data is also permitted. The tools supported under this FOA will make use of relevant data standards and will be built so that they can be integrated into the data repositories, both of which are created in awards under the other FOAs of the BRAIN initiative informatics program. The tools must be user-friendly in accessing and analyzing data from appropriate data archives, and should analyze/visualize data without requiring users to download data. The tools should also allow data to be combined for analysis/visualization from multiple locations.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-220.html

Application date line:

June 10, 2022,

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

11. Understanding Suicide Risk and Protective Factors among Black Youth (R21 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) aims to advance translational research to better understand factors that confer risk and resilience for suicide among Black youth. R21 exploratory grant awards in response to this FOA are intended to conduct preliminary work regarding the assessment and characterization of risk and protective factors, with consideration for the identification of novel targets for future development of prevention and intervention efforts. Studies may involve evaluating the relevance of risk and protective factors for Black youth and their families, identifying risk or protective factors (or their interactions) unique to Black youth (or subgroups of this population), developing new or adapted assessment methods that are developmentally and culturally appropriate, and/or examining the acceptability and utility of existing assessment methods.This FOA supports exploratory developmental projects focused on refining strategies for the assessment and characterization of risk and protective factors and collecting preliminary data needed as a pre-requisite to a larger-scale, definitive project. A companion R01 FOA (RFA-MH-22-140) supports larger scale projects that are of sufficient scope and are powered to provide a definitive examination of risk/protective factors associated with suicide risk among Black youth.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-141.html

Application Date Line: October 19, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

12. Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)

Avenir means future in French, and this Avenir Award Program looks toward the future by supporting early stage investigators proposing highly innovative research in the area of chemistry and pharmacology of substance use disorders and addiction. The purpose of this award is to support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow’s leaders in the field.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-014.html

Application Date Line: August 11, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

13. Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high value informatics research resources to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on sustaining operations and improving the user experience and availability of existing, widely-adopted informatics tools and resources. This is in contrast to early-stage and advanced development efforts to generate these tools and resources that are supported by companion ITCR FOAs. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, the proposed sustainment plan must provide clear justification for why the research resource should be maintained and how it has benefitted and will continue to benefit the cancer research field. In addition, mechanisms for assessing and maximizing the value of the resource to researchers and supporting collaboration and deep engagement between the resource and the targeted research community should be described.

Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-024.html

Application Date Line: June 14, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

14. Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated prospective observational comparative effectiveness research (CER) to the National Institute of Neurological Disorders and Stroke (NINDS) (note: only prospective observational studies will be considered). The study must address questions within the mission and research interests of the NINDS and may evaluate preventive strategies, diagnostic approaches, or interventions including drugs, biologics, and devices, or surgical, behavioral, and rehabilitation therapies. NINDS is particularly interested in pragmatic study designs that utilize a cost-effective means of prospectively collecting observational data important to current clinical practice.

Link: https://grants.nih.gov/grants/guide/pa-files/PAR-22-076.html

Application Date Line: June 17, 2022,

No late applications will be accepted for this Funding Opportunity Announcement

All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

PhD Opportunity: Call for Applications

PhD studentship in Surgical Disciplines at University of Bergen Norway

The Kamuzu University of Health Sciences (KUHES) together with Queen Elizabeth Central Hospital  (QECH) and Kamuzu Central Hospital (KCH) has received a grant from the Norwegian Agency for Development Cooperation (NORAD), under the the Norwegian Programme for Capacity Building in Higher Education and Research for Development (NORHED II), and plans to use the funds to strengthen clinical, academic and research capacity in surgical specialties as well as related specialties of anaesthesia, radiology and pathology. NORHED II will run from 2021 to 2026.

KUHES is therefore calling for applications from suitable candidates to be considered for 4 PhD studentships in surgical fields at university of Bergen (UoB) Norway. KUHES as a grant holder will facilitate with the selection process, identification of local supervisors as well as for other logistical support.

Site

This a PhD by research and publication offered by UoB. The candidate will be based in Malawi, where the research will be conducted, but will have prescribed courses and other academic activities done in Norway. 2 candidates will be based in Lilongwe at Kamuzu Central Hospital (KCH) and 2 will be based in Blantyre at KUHES / QECH.

Commencement

PhD studentships at UoB start at any time. Those successful in the interview will be able to commence the application process with the university as soon after the local interviews as possible.

Duration

The PhD Studentships will typically be for 3-5 years depending on individual progress. It is envisaged that the student will complete the training within the lifespan of the grant – by 2026.

Eligibility

The applicant must:

  • Be Malawian
  • Have an MBBS degree
  • Have a postgraduate surgical qualification such as an MMed or Fellowship. All surgical specialties will be considered. Medical graduates with other postgraduate qualifications such as Public Health and Epidemiology may be considered
  • Be in clinical practice and have current registration with the Medical council of Malawi
  • Be currently employed in the public sector such as with Ministry of Health or KUHES

Stipend

Those successful will be eligible for:

  • A training stipend
  • A research grant to conduct research locally
  • Travel, accommodation and other logistical expenses when going and spending time in Norway.
  • Other logistical support to registration and completion of the PhD studentship at UoB.

The specific amounts will be made known to the successful candidates. It is advisable for the candidate to have other forms of income such as a salary form an employer as the grant will not be able to pay a full local salary and other employment benefits

Application Process

Applicants should submit:

  • An application letter
  • A full CV including full contact details of two referees, who will be asked to submit reference letters directly to KUHES
  • Academic transcripts
  • A brief Academic Statement of Purpose – defining and discussing goals; need and justification of intended research areas; and how you previous training, education and experience makes you the best fit.
  • Certified copies of all academic qualifications
  • Certified copies of registration including a ‘letter of good standing’ from relevant regulatory authorities such as the Medical Council of Malawi
  • Supporting letter from current employer
  • Proof of payment of a non-refundable application fee of MK10000.00 with payment made to:

COM POSTGRADUATE POOL

NATIONAL BANK OF MALAWI

CHICHIRI BRANCH

ACCOUNT NUMBER : 698881

ACCOUNT TYPE: CURRENT

All the above documents shall be submitted to:

The Registrar

Kamuzu University of Health Sciences

Private Bag 360

Chichiri

Blantyre 3, Malawi

Attention: Assistant Registrar (Academic)

Tel: + 265 (0) 1 874 107, Fax +265 (0) 1 874 700

E-mail: admissions@medcol.mw

Copy:   postgraduateadmin@medcol.mw

            nmkandawire@kuhes.ac.mw

            sven.young@uib.no

Closing date for receiving applications: 31st March, 2022

Only shortlisted candidates will be called for interviews.

KUHES, UNVERSITY OF BERGEN AND NORAD STRIVE FOR EQUAL OPPORTUNITY FOR ALL APPLICANTS.

TRAINING CALENDAR

We are pleased to share with you our training calendar for the January-June 2022 period which can be accessed on the following link: http://www.rsc.medcol.mw/wp-content/uploads/2022/01/Training-Calendar-Jan-to-June-2022-1.pdf

If you have any other courses that you would like to be trained in do not hesitate to contact us. We have qualified trainers in Monitoring and Evaluation, Data Management, Project Management, Biostatistics, Good Clinical Practice, Manuscript Writing and several other courses. 

RSC organises tailor-made courses to meet your requirements. We offer the courses in Blantyre, Lilongwe, Mangochi but also at any venue suitable for you. We also offer certificates upon successful completion of the course.

For further details, write to us on rsctrainingcoordination@kuhes.ac.mw and rscinfo@kuhes.ac.mw

Congratulations to KUHeS researchers

Congratulations to KUHeS researchers Jessy Goupeyou-Youmsi and Dr. Evelyn Olanga for being awarded the Pan African Mosquito Control Association Early career and Mid-career awards  respectively.

Jessy joined the Malaria Alert Centre of the Kamuzu University of Health Sciences in Malawi in January 2019 where she works as a Postdoctoral Research fellow under Malawi International Center of Excellence for Malaria Research (ICEMR). She is currently working on a project characterizing Plasmodium transmission reservoirs in Malawi and another project assessing the vector competence of local malaria vectors, both under the Malawi ICEMR. For the past two years, Jessy has been an active member of the Vector Control Technical Working Group (VCTWG) supporting the NMCP, Malawi.

Jessy Goupeyou

Speaking after receiving the award Jessy said;

“Vector-borne diseases (VBDs) cause more than 700,000 deaths annually. It is reported that the burden of VBDs is highest in tropical and subtropical areas, and that they disproportionately affect the poorest populations. To be recognized by the PAMCA WIVC for my role in the control of VBDs in SSA is a great honor and a privilege. Therefore, I take this opportunity to thank PAMCA WIVC initiative for this great initiative and for bringing people together, especially for giving us, young female researchers in vector control, a platform to share our research ideas and establish networking.”

Dr. Evelyn Olanga obtained her PhD in Medical Entomology in 2016 and her training at the International Centre of Insect Physiology and Ecology (icipe), Kenya. Since then, she has been a Postdoctoral research scientist at the Malaria Alert Centre (MAC) of the Kamuzu University of Health Sciences. She has conducted field studies characterizing mosquito behaviour and the risk of malaria in endemic districts in southern and central Malawi.

Speaking after receiving the award Dr. Evelyn said;

Dr. Olanga

 “I feel blessed to be the first recipient of the PAMCA WIVC mid-career Excellence Award. I’m aware that not every African woman gets the chance to participate in addressing development issues and research, let alone win an award. This award serves as an on-going reminder that women can still achieve their dreams, even after taking a break from science and research. Therefore, in the spirit of this award I challenge women to believe in themselves, even if you are facing some challenges. There is still a lot of work to be done in the fight against vector-borne diseases and the contribution of women is valuable in making Africa disease-free.”  

The Excellence Award Ceremony was a chance to recognise phenomenal women working in the field; celebrate rising stars and women who have contributed exceptionally to research and leadership in the control of VBDs in sub-Saharan Africa (SSA). A total of 36 applications were received and awardees were competitively selected based on pre-determined criteria. Following an application and extensive review process by a selection committee, five women were awarded Excellence Awards under three categories; early-career, mid-career, and senior-career. Category winners were awarded with a grant of $2000, and runners up received $1000. The awardees will re-invest the funds in initiatives that will continue to promote women participation in VBDs.

Training Opportunity: PhD and MSc Studies

Recruiting postgraduate students for “ImplementOneHealth”
Delivering a One Health programme of research working towards the elimination of rabies in Malawi

Three PhD students and between 1-3 MSc students will be recruited in Malawi and will be associated with
Universities in Malawi, funded by a grant from the Research Council of Norway. The grant will fund three Malawian PhD students covering a range of topics from bioinformatics and genomic surveillance to social science and implementation research to develop and evaluate this intervention(s). Each student will have both
Malawi and Norwegian supervisors with additional supervisors from the University of Glasgow. We envisage a
close collaboration between the students and the supervisory groups, with the aim to develop true One Health
professionals able to work across disciplines.

1st Studentship:
This student will have a veterinary or equivalent natural science background relevant to animal health AND
One Health and their main focus will be rabies virus epidemiology in Malawi. The student will be associated
with the Central Veterinary Laboratory (CVL) and will enrol at Lilongwe University of Agriculture and Natural
Resources (LUANAR), which provides veterinary education in Malawi. The supervisory team is led by Dr.
Hannah Joan Jørgensen (NVI) with Drs. Joseph Nkhoma or Gilson Njunga (CVL), Dr. Siv Klevar (NVI) and Drs.
Roman Biek or Kirstyn Bunker (UofG). This student will visit Glasgow University for training.

2nd Studentship:
This student will have a social science or natural science background and will focus on civil society engagement
in operationalization of One Health. The student will be closely associated with a civil society organization and
will enroll at LUANAR. The supervisory team is led by Dr. Ana Lorena Ruano with Dr. Shokouh Makvandi-Nejad
(NVI) and Dr. Evelyn Banda (PHIM) a Malawian co-supervisor with a social science background. This student
will visit the University of Bergen for training.

3rd Studentship:
This student will have a background from Public Health sciences and be mainly associated with the Public
Health Institute of Malawi (PHIM). The student will enrol at Kamuzu University of Health Sciences in Malawi
and defend his/her thesis there. The work will involve public health aspects of rabies control with a focus on
One Health surveillance of rabies in Malawi. The supervisory team is led by Dr. Evelyn Banda (PHIM) with Dr.
Siri Feruglio (NIPH), Joseph Nkhoma (CVL) and Dr. Hannah Jørgensen (NVI). This student will visit The NIPH and
NVI for training.

MSc students
Students will enter the One Health master’s program presently under establishment at Malawi University of
Science and technology and will have research costs covered including overseas training visits depending on
their particular specializations.

If you are eligible, please get in touch by emailing katie.hampson@glasgow.ac.uk for more details and application processes.


oral sex with hotties movie sex scene teen pussy www xxvideo com More than just erotic film Anal with hot Latina babe Foxy hottie loves anal